Xenon Pharmaceuticals (XENE) Receivables (2013 - 2025)
Xenon Pharmaceuticals (XENE) reported Receivables of $8.65 million for Q1 2025, up 938.3% from $833,000 a year earlier and up 194.4% from the prior quarter.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Receivables (2013 - 2025) Analysis & Trends
At the end of FY2024, Xenon Pharmaceuticals posted Receivables of $2.94 million, up 236.2% from FY2023.
- Receivables has a five-year compound annual growth rate of 18.4% (FY2019 to FY2024).
- By year, Receivables came in at $874,000 in FY2023 (-11.4%), $986,000 in FY2022 (-64.3%), $2.77 million in FY2021 (+51.8%) and $1.82 million in FY2020 (+44.5%).
- The Q1 2025 figure ranks as the highest quarterly Receivables in data going back to Q4 2013.
- Year over year, Receivables has now increased in each of the last three quarters, with growth averaging 121.7% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q2 2020 (growth of 944.4%); the low point was Q3 2023 (a decline of 67.6%).
- Per Business Quant data, the three quarters before Q1 2025 came in at $2.94 million (Q4 2024), $938,000 (Q3 2024) and $853,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Xenon Pharmaceuticals | 3.55 Bn | 3.55 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 8.65 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | 938,000.00 |
| Jun 30, 2024 | 853,000.00 |
| Mar 31, 2024 | 833,000.00 |
| Dec 31, 2023 | 874,000.00 |
| Sep 30, 2023 | 805,000.00 |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 986,000.00 |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 2.92 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | 3.24 Mn |
| Jun 30, 2021 | 2.92 Mn |
| Mar 31, 2021 | 5.06 Mn |
| Dec 31, 2020 | 1.82 Mn |
| Sep 30, 2020 | 1.61 Mn |
| Jun 30, 2020 | 1.79 Mn |
API Access
Xenon Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=XENE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "XENE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=XENE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();